Aceto Acquires Biotron Laboratories and Talus Mineral Company
Aceto has acquired Biotron Laboratories and Talus Mineral Company.
Aceto announced on March 2, 2022 that it has acquired Biotron Laboratories and Talus Mineral Company (collectively referred to as Biotron). Biotron manufactures specialty ingredients for the nutritional supplements industry and is known for its technology for its amino-acid based chelation production. Aceto’s nutraceuticals and life science business will be expanded due to the acquisition.
“Biotron is the latest of our recent acquisitions of exceptional life-science specialty manufacturers, and they bring important new capabilities to Aceto,” said Gilles Cotter, CEO of Aceto, in a press release. “Over four decades they have built a strong reputation in the nutritional supplements industry for their unique mineral chelation process, high-quality trace elements, and other specialty ingredients. They are known for their focus on R&D and ability to work with customers on a variety of custom and specialty orders. Biotron is a great addition to our already-substantial nutraceuticals business, with a complementary portfolio of customers. We are delighted to welcome them to the growing Aceto family of life science specialty manufacturers and suppliers.”
Source: Aceto
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
